Skip to main content

FDA Approvals

FDA Approvals
Simbrinza (Brinzolamide/Brimonidine Tartrate) Receives FDA Approval for the Treatment of Open-Angle Glaucoma or Ocular Hypertension
Loretta Fala
Read More
FDA Approvals
Ilaris (Canakinumab) Receives a New Indication for the Treatment of Systemic Juvenile Idiopathic Arthritis
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Kadcyla (Ado-Trastuzumab Emtansine): First Antibody-Drug Conjugate Approved for the Treatment of HER2-Positive Metastatic Breast Cancer
Lisa A. Raedler, PhD, RPh
Read More
Payers' Guide, FDA Approvals
Zaltrap: A New Option for the Treatment of Patients with Metastatic Colorectal Cancer Resistant to or Progressing After an Oxaliplatin-Containing Regimen
Lynne Lederman, PhD, Medical Writer
Read More
Payers' Guide, FDA Approvals
Zytiga Receives an Expanded Indication for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy
Loretta Fala
Read More
Payers' Guide, FDA Approvals
Zioptan Receives FDA Approval for Patients with Open-Angle Glaucoma and/or Ocular Hypertension
Loretta Fala
Read More
Payers' Guide, FDA Approvals
Linzess: A Novel Treatment Option for Constipation Associated with Irritable Bowel Syndrome
Alice Goodman, Medical Writer
Read More
Payers' Guide, FDA Approvals
Perjeta: A New Option for Patients with HER2-Positive Metastatic Breast Cancer
Alice Goodman, Medical Writer
Read More
FDA Approvals, Payers' Guide
Trends in the 2013 Pharmaceutical Pipeline
Dalia Buffery, MA, ABD, Atheer A. Kaddis, PharmD
Read More
Page 47 of 53
Results 461 - 470 of 522